SVHH.F vs. GSK
Compare and contrast key facts about Svenska Handelsbanken AB (SVHH.F) and GlaxoSmithKline plc (GSK).
Performance
SVHH.F vs. GSK - Performance Comparison
Loading graphics...
SVHH.F vs. GSK - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
SVHH.F Svenska Handelsbanken AB | -6.74% | 24.47% | 1.88% | 5.56% | 0.40% | 20.53% | -8.79% | 3.34% | -17.01% | -13.90% |
GSK GlaxoSmithKline plc | 16.86% | 33.29% | 1.12% | 6.42% | -29.29% | 36.22% | -24.50% | 32.16% | 19.13% | -14.89% |
Different Trading Currencies
SVHH.F is traded in EUR, while GSK is traded in USD. To make them comparable, the GSK values have been converted to EUR using the latest available exchange rates.
Returns By Period
In the year-to-date period, SVHH.F achieves a -6.74% return, which is significantly lower than GSK's 15.25% return. Over the past 10 years, SVHH.F has underperformed GSK with an annualized return of 1.90%, while GSK has yielded a comparatively higher 5.58% annualized return.
SVHH.F
- 1D
- 1.62%
- 1M
- -14.44%
- YTD
- -6.74%
- 6M
- 2.80%
- 1Y
- 10.22%
- 3Y*
- 13.44%
- 5Y*
- 6.15%
- 10Y*
- 1.90%
GSK
- 1D
- 0.00%
- 1M
- -4.28%
- YTD
- 15.25%
- 6M
- 25.12%
- 1Y
- 41.48%
- 3Y*
- 17.88%
- 5Y*
- 9.15%
- 10Y*
- 5.58%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SVHH.F vs. GSK — Risk / Return Rank
SVHH.F
GSK
SVHH.F vs. GSK - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Svenska Handelsbanken AB (SVHH.F) and GlaxoSmithKline plc (GSK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| SVHH.F | GSK | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.28 | 1.47 | -1.19 |
Sortino ratioReturn per unit of downside risk | 0.58 | 2.07 | -1.49 |
Omega ratioGain probability vs. loss probability | 1.09 | 1.27 | -0.17 |
Calmar ratioReturn relative to maximum drawdown | 0.47 | 2.48 | -2.01 |
Martin ratioReturn relative to average drawdown | 1.62 | 5.95 | -4.33 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| SVHH.F | GSK | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.28 | 1.47 | -1.19 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.20 | 0.37 | -0.17 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.06 | 0.25 | -0.18 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.00 | 0.22 | -0.22 |
Correlation
The correlation between SVHH.F and GSK is 0.05, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
SVHH.F vs. GSK - Dividend Comparison
SVHH.F's dividend yield for the trailing twelve months is around 1.30%, less than GSK's 3.14% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SVHH.F Svenska Handelsbanken AB | 1.30% | 1.03% | 1.05% | 0.66% | 0.47% | 0.39% | 6.34% | 0.52% | 0.75% | 0.44% | 0.46% | 0.48% |
GSK GlaxoSmithKline plc | 3.14% | 3.42% | 4.60% | 3.75% | 5.47% | 4.99% | 5.59% | 4.35% | 5.65% | 5.83% | 6.86% | 5.93% |
Drawdowns
SVHH.F vs. GSK - Drawdown Comparison
The maximum SVHH.F drawdown since its inception was -100.00%, which is greater than GSK's maximum drawdown of -44.08%. Use the drawdown chart below to compare losses from any high point for SVHH.F and GSK.
Loading graphics...
Drawdown Indicators
| SVHH.F | GSK | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -100.00% | -55.70% | -44.30% |
Max Drawdown (1Y)Largest decline over 1 year | -21.57% | -14.80% | -6.77% |
Max Drawdown (5Y)Largest decline over 5 years | -27.53% | -50.10% | +22.57% |
Max Drawdown (10Y)Largest decline over 10 years | -51.15% | -50.10% | -1.05% |
Current DrawdownCurrent decline from peak | -100.00% | -7.75% | -92.25% |
Average DrawdownAverage peak-to-trough decline | -99.90% | -18.90% | -81.00% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.31% | 6.38% | -0.07% |
Volatility
SVHH.F vs. GSK - Volatility Comparison
Svenska Handelsbanken AB (SVHH.F) has a higher volatility of 17.50% compared to GlaxoSmithKline plc (GSK) at 6.47%. This indicates that SVHH.F's price experiences larger fluctuations and is considered to be riskier than GSK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| SVHH.F | GSK | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 17.50% | 6.47% | +11.03% |
Volatility (6M)Calculated over the trailing 6-month period | 23.77% | 19.11% | +4.66% |
Volatility (1Y)Calculated over the trailing 1-year period | 34.29% | 28.39% | +5.90% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 30.04% | 24.66% | +5.38% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 29.67% | 22.82% | +6.85% |
Financials
SVHH.F vs. GSK - Financials Comparison
This section allows you to compare key financial metrics between Svenska Handelsbanken AB and GlaxoSmithKline plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities